GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioNxt Solutions Inc (FRA:BXT) » Definitions » EV-to-Revenue

BioNxt Solutions (FRA:BXT) EV-to-Revenue : 1,495.48 (As of May. 31, 2025)


View and export this data going back to 2019. Start your Free Trial

What is BioNxt Solutions EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BioNxt Solutions's enterprise value is €43.37 Mil. BioNxt Solutions's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €0.03 Mil. Therefore, BioNxt Solutions's EV-to-Revenue for today is 1,495.48.

The historical rank and industry rank for BioNxt Solutions's EV-to-Revenue or its related term are showing as below:

FRA:BXT' s EV-to-Revenue Range Over the Past 10 Years
Min: 71.86   Med: 248.09   Max: 1931.81
Current: 1614.42

During the past 6 years, the highest EV-to-Revenue of BioNxt Solutions was 1931.81. The lowest was 71.86. And the median was 248.09.

FRA:BXT's EV-to-Revenue is ranked worse than
99.49% of 975 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs FRA:BXT: 1614.42

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-31), BioNxt Solutions's stock price is €0.32. BioNxt Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00. Therefore, BioNxt Solutions's PS Ratio for today is .


BioNxt Solutions EV-to-Revenue Historical Data

The historical data trend for BioNxt Solutions's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNxt Solutions EV-to-Revenue Chart

BioNxt Solutions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial 236.88 340.88 306.83 195.45 152.14

BioNxt Solutions Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.54 152.14 272.42 1,183.82 858.31

Competitive Comparison of BioNxt Solutions's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNxt Solutions's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's EV-to-Revenue falls into.


;
;

BioNxt Solutions EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BioNxt Solutions's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=43.369/0.029
=1,495.48

BioNxt Solutions's current Enterprise Value is €43.37 Mil.
BioNxt Solutions's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNxt Solutions  (FRA:BXT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BioNxt Solutions's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.32/0
=

BioNxt Solutions's share price for today is €0.32.
BioNxt Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNxt Solutions EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioNxt Solutions's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNxt Solutions Business Description

Traded in Other Exchanges
Address
1820 Fir Street, Suite 270, Vancouver, BC, CAN, V6J 3B1
BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.

BioNxt Solutions Headlines

No Headlines